By blocking this interaction, the anti-CD47 antibody magrolimab has been shown to unmask “eat-me” signals and induce macrophage-induced phagocytosis in cancer cell lines and ovarian cancer xenografts [62,72]. The gene discussed is CD47; the disease is cancer.